Taiwan and China step up anti-counterfeiting measures
This article was originally published in Scrip
Taiwan is stepping up efforts to combat counterfeit drugs through a series of initiatives including the use of near-infrared spectrography (NIR) technology. The wider adoption of the rapid identification technique is one of the Department of Health's main goals for this year.
You may also be interested in...
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.